Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
LDOS · 10-Q filed August 4, 2026

LDOS earnings analysis

What we found in LDOS's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Leidos delivered 7.2% year-over-year Q2 revenue growth to $4.558 billion, led by a 32.0% Homeland increase and continued Intelligence & Digital and Defense growth, with bookings rising to $4.9 billion and backlog reaching $48.711 billion. However, operating margin declined to 11.3% from 13.4%, GAAP EPS was $2.81 versus $3.01 a year earlier, and Health weakened on lower volumes. Cash generation was a major offset, with $793 million of operating cash flow and $761 million of free cash flow, although acquisition financing lifted debt to $6.0 billion.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue and bookings accelerated
Q2 revenue rose 7.2% year over year to $4.558 billion from $4.253 billion, and increased 3.6% sequentially from $4.400 billion in Q1 2026. Net bookings were $4.9 billion versus $3.9 billion a year earlier.
Homeland posted outsized growth
Homeland was the principal growth engine: revenue increased 32.0% to $1.018 billion and operating income increased 43.8% to $92 million. Growth included $141 million of Entrust acquisition revenue and a $14 million favorable FX effect.
Operating cash flow rose sharply
Operating cash flow was $793 million, up $307 million from $486 million a year ago, driven by favorable working-capital changes, prior-year excess tax payments and payroll/benefit payment timing. Quarterly free cash flow was $761 million.
Backlog expanded, led by funded work
Total backlog reached $48.711 billion, up $2.501 billion from $46.210 billion a year earlier. Funded backlog increased to $10.223 billion from $7.122 billion, while Defense backlog grew to $13.756 billion from $10.598 billion.
Core government segments grew
Intelligence & Digital revenue increased 6.5% to $1.499 billion and Defense revenue increased 6.2% to $955 million, primarily reflecting program wins and increased contract volumes. Intelligence & Digital operating income rose 5.2% to $142 million.
Lower tax rate partly cushioned earnings
The effective tax rate fell to 21.1% from 24.1% a year ago, helping offset the decline in income before taxes to $451 million from $518 million.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Margins and GAAP earnings declined
Operating margin contracted 210 basis points year over year to 11.3% from 13.4%, while net income attributable to common stockholders fell 9.5% to $354 million from $391 million. Corporate operating loss widened to $58 million from $9 million, including higher acquisition and integration costs.
Health volumes pressured profit
Health revenue declined 7.6% to $1.086 billion and segment operating income fell 16.2% to $254 million; management attributed both declines to lower volumes. Health operating margin fell to 23.4% from 25.8%.
Entrust financing increased leverage
Debt increased to $6.0 billion at July 3, 2026 from $4.6 billion at January 2, 2026 after issuance of $600 million of 4.10% notes and $800 million of 5.00% notes to help fund Entrust. Quarterly non-operating expense increased to $63 million from $53 million, principally on higher interest expense.
Federal funding concentration remains
Approximately 83% of Q2 revenue came from U.S. government contracts, and management said a short-term continuing resolution is increasingly expected beyond the September 30, 2026 funding deadline; failure to enact appropriations or a CR could cause a full or partial shutdown.
No material risk-factor updates
There were 0 material changes to risk factors from the January 2, 2026 Form 10-K, according to Item 1A. The filing nevertheless flags tariff, foreign-exchange and geopolitical exposure, with international sales representing 9% of Q2 revenue.
The numbers

What they reported.

What the company itself reported, taken out of the document.

Earnings per share
$2.81
Operating margin
11.3%
Segment
Intelligence & Digital revenue: $1.499 billion, up 6.5% year over year from $1.408 billion.
Segment
Health revenue: $1.086 billion, down 7.6% year over year from $1.175 billion.
Segment
Homeland revenue: $1.018 billion, up 32.0% year over year from $771 million.
Segment
Defense revenue: $955 million, up 6.2% year over year from $899 million.
Guidance

What they said about what is next.

The 10-Q contains no explicit quantitative earnings or revenue outlook. Management stated it anticipates meeting liquidity needs over the next 12 months through operating cash flow, available cash, commercial paper, potential receivables sales and, if needed, revolver borrowings.

How we read the filing overall

The filing reads about the same as the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · May 5, 2026
Leidos reported Q1 2026 revenues of $4.4 billion, representing a 3.7% increase from $4.25 billion in the prior year. However, diluted EPS was $2.56, missing the analyst expectation of $2.90, showing a decline from the…
10-K · February 17, 2026
Leidos emphasizes mission-critical, technology-enabled services across five strategic pillars (space & maritime; energy infrastructure; digital modernization & cyber; mission software; managed health services) and…
10-Q · August 5, 2025
Leidos reported Q2 revenues of $4,253 million, up $121 million (+2.9%) versus the prior-year quarter, with operating income of $571 million and diluted EPS of $3.01 (vs $2.37 a year ago). Cash generation improved (net…
10-Q · May 6, 2025
Leidos reported quarterly revenue of $4,245.0 million (up $270.0 million, +6.8% vs. the prior-year quarter) and diluted EPS of $2.77 (up $0.70 vs. $2.07 a year ago). Gross margin expanded to ~17.8% and operating margin…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing LDOS makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever